For example, CAR-T cells engineered to express chemokine receptors such as CXCR1, CXCR2, or CCR2 demonstrate enhanced migration toward tumor sites that secrete corresponding chemokines, such as CXCL8 for CXCR1/2 and CCL2 for CCR2. The gene discussed is CCR2; the disease is neoplasm.